Collaboration builds upon Syngoi’s synthetic DNA manufacturing capabilities and Ribbon’s algorithm-driven technology to produce pristine…
Continue Reading-
Pharming Technologies B.V. declares unconditional and completes the recommended cash offer to the shareholders of Abliva AB (publ) and extends the acceptance period
Pharming Technologies B.V. declares unconditional and completes the recommended cash offer to the shareholders of…
Continue Reading -
Neuro Event Labs Oy raises €2.0M investment for commercial expansion in Europe and US market entry of its AI-powered seizure detection device for epilepsy.
Tampere, Finland – 12 February 2025: Neuro Event Labs Oy today announced it has raised…
Continue Reading